Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTSL.L Regulatory News (TSL)

  • There is currently no data for TSL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Clarifications RE: Scheme Implementation Deed

3 Aug 2022 07:00

RNS Number : 6856U
ThinkSmart Limited
03 August 2022
 

3 August 2022

 

ThinkSmart Limited

 ("ThinkSmart" or the "Company" which together with its subsidiaries is the "Group")

 

Clarifications RE: Scheme Implementation Deed

 

 

ThinkSmart wishes to provide an update following the 29 July 2022 announcement in order to clarify certain aspects of the Scheme.

 

Since receiving its Block shares, the Board of ThinkSmart has been disappointed by the discount that ThinkSmart's share price has traded at relative to the Block share price and has considered a number of options to maximise shareholder value.

 

The Independent Board Committee ("IBC") of ThinkSmart, which unanimously recommended the Scheme, believes the proposed transaction to be in the best interests of all ThinkSmart shareholders and wishes to make the following clarifications:

 

1. ThinkSmart shareholders will receive cash consideration equal to the proceeds realised from the post-Scheme implementation sale on the NYSE of the Block shares (net of their proportion of the 0.5% sale fees and after conversion into Pounds Sterling or Australian dollars (as applicable))(1).

 

2. The consideration will be paid to shareholders in cash post-Scheme implementation, anticipated to be November 2022.

 

3. Whilst this will result in ThinkSmart selling its shareholding in Block, ThinkSmart shareholders can choose to purchase shares in Block on-market thereby enabling them to have a direct exposure to Block shares rather than through a shareholding in ThinkSmart.

 

4. Shareholders in ThinkSmart will be able to continue to trade ThinkSmart shares on the London Stock Exchange up until the Scheme is implemented.

 

5. The IBC believes that the value within ThinkSmart today is its shareholding in Block. Thus, the benefits of maintaining a listing on AIM, such as accessing equity capital markets, are no longer relevant.

 

The IBC therefore re-affirms its unanimous recommendation that ThinkSmart shareholders vote in favour of the Scheme, in the absence of a superior proposal and subject to an independent expert opining that the Scheme is in the best interests of ThinkSmart shareholders. Further details about the Scheme will be contained in a Scheme Booklet that will be sent to shareholders in due course.

 

Defined terms within this announcement should be taken to mean the same as that set out in the 29 July 2022 announcement by ThinkSmart.

 

(1) Depositary interest holders will receive the Scheme consideration in Pounds Sterling and holders of ThinkSmart shares that do not hold via depositary interests will receive the Scheme consideration in Australian dollars unless they elect to receive the Scheme consideration in Pounds Sterling. ThinkSmart shareholders will be bearing all risks associated with any currency conversions required in connection with the sale of the Block shares and the payment of the Scheme consideration to them.

 

-ENDS-

 

 

For further information please contact:

 

ThinkSmart Limited

Via Buchanan

Canaccord Genuity Limited (Nominated Adviser and Broker)

Andrew Potts

Tom Diehl

 

+44 (0)20 7523 8350

 

 

 

 

Buchanan

Giles Stewart

Chris Lane

Toto Berger

 

+44 20 7466 5000

 

Notes to Editors

 

About ThinkSmart Limited

 

ThinkSmart's roots are as a specialist digital payments platform business. Following the sale of its remaining 10% shareholding in Clearpay in January 2022, the Group holds shares in NYSE listed Block, Inc (NYSE: SQ). The Group also provides an outsourced call centre customer service and support service to Clearpay and is managing the wind-down of its leasing business.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSFFWEEESELA
Date   Source Headline
22nd Dec 20164:42 pmRNSBuy-back class ruling
22nd Dec 20163:05 pmRNSGrant of LTIP Awards
16th Dec 20168:02 amRNSAppointment of Joint Corporate Broker
15th Dec 20167:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Dec 20165:00 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Dec 20167:00 amRNSChange in ISIN and SEDOL
2nd Dec 20168:06 amRNSAdmission to AIM and First Day of Dealings
21st Apr 20082:47 pmRNSIssue of Equity-TissueScience
8th Apr 20082:26 pmRNSTissue Science Equity Issue
2nd Apr 20084:44 pmRNSTissue Science Laboratories
2nd Apr 200812:18 pmRNSTissue Science Laboratories
1st Apr 20087:57 amRNSEPT Disclosure
28th Mar 20083:26 pmRNSHolding(s) in Company
28th Mar 200812:02 pmRNSHolding(s) in Company
28th Mar 20087:02 amRNSRule 8.1- Tissue Science Lab
27th Mar 200811:41 amRNSHolding(s) in Company
27th Mar 20089:47 amRNSRule 8.1 - Tissue Science Lab
25th Mar 20087:01 amRNSRule 8.1- Tissue Science Lab.
19th Mar 200811:29 amRNSHolding(s) in Company
19th Mar 20089:29 amRNSRule 8.1- Tissue Science Lab.
18th Mar 20089:25 amRNSRule 8.1- Tissue Science Lab.
18th Mar 20089:22 amRNSRule 8.1- Tissue Science Lab.
14th Mar 20084:31 pmRNSRule 8.3- Tissue Science
14th Mar 20082:21 pmRNSRule 8.3- Tissue Science
14th Mar 200811:38 amRNSHolding(s) in Company
14th Mar 200811:38 amRNSHolding(s) in Company
14th Mar 200811:15 amRNSRule 8.3- Tissue Science
14th Mar 20088:09 amRNSRule 8.1- Tissue Science Lab
13th Mar 20082:26 pmBUSRule 8.3 - Tissue Science Laboratories Plc
13th Mar 20082:05 pmRNSRule 8.1- Tissue Science Lab.
13th Mar 20081:07 pmRNSEPT Disclosure-Amend
13th Mar 200811:05 amPRNRule 8.3 - Tissue Science Laboratories Plc
13th Mar 20088:36 amRNSEPT Disclosure
13th Mar 20087:00 amRNSRule 8.1- Tissue Science Lab.
12th Mar 20083:55 pmRNSOffer Document Posted
12th Mar 20087:01 amRNSOffer for Tissue Science Lab.
12th Mar 20087:01 amRNSFinal Results & Cash Offer
17th Jan 20087:00 amRNSPositive Study Results
12th Nov 200710:47 amRNSHolding(s) in Company
7th Nov 20074:22 pmRNSHolding(s) in Company
28th Sep 20077:02 amRNSInterim Results
10th Sep 20077:01 amRNSNotice of Results
28th Aug 200712:26 pmRNSHolding(s) in Company
17th Aug 20073:28 pmRNSAIM Rule 26 Compliance
6th Jul 20072:25 pmRNSResult of AGM
6th Jul 20077:00 amRNSPre-close Trading Statement
29th Jun 20074:00 pmRNSTotal Voting Rights
14th Jun 20077:00 amRNSNotice of AGM
31st May 200712:00 pmRNSExercising of Options
16th Apr 20077:01 amRNSR&D Teach-In

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.